| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 22 |
| 1 | TACROLIMUS | 17 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 17 |
| 3 | TACROLIMUS OINTMENT 0.1% | 17 |
| 4 | ADALIMUMAB | 13 |
| 5 | SIROLIMUS | 9 |
| 6 | INFLIXIMAB | 8 |
| 7 | METHOTREXATE | 8 |
| 8 | METHOTREXATE SODIUM | 8 |
| 9 | NIVOLUMAB | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DONOR HUMAN STOOL | 1 | 0.0043 |
| 1 | TEPLIZUMAB-MZWV | 1 | 0.0014 |
| 2 | PERPHENAZINE | 2 | 0.0010 |
| 3 | SIROLIMUS | 9 | 0.0007 |
| 4 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| 5 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 1 | 0.0004 |
| 6 | FIDAXOMICIN | 1 | 0.0004 |
| 7 | HYDROXOCOBALAMIN | 1 | 0.0002 |
| 8 | SALINE NASAL SPRAY | 1 | 0.0002 |
| 9 | GARLIC | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD3-directed Antibody [EPC] | 1 | 0.0014 |
| 1 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 2 | Iron Chelator [EPC] | 6 | 0.0002 |
| 3 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 5 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 9 | 0.0001 |
| 7 | CTLA-4-directed Blocking Antibody [EPC] | 4 | 0.0001 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 9 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |